市场调查报告书
商品编码
1517285
两片空心硬胶囊的全球市场:按原料、尺寸、最终用户和地区进行预测(~2032 年)Global Two-Piece Empty Hard Capsule Market Research Report Information by Raw Material (Gelatin Hydroxypropyl Methylcellulose, Starch and Pullulan), By size, By End Users And by Region - Forecast Till 2032 |
两片空心硬胶囊的市场规模预计到 2023 年为 11.3 亿美元,到 2024 年为 12.3 亿美元,预测期内复合年增长率为 7.08%,预计到 2032 年将达到 22.3 亿美元。
两片装空心硬胶囊市场正在迅速扩大,这主要是由于非传染性疾病(NCD)盛行率的上升。世界卫生组织(WHO)估计,到2023年,非传染性疾病每年将导致4,100万人死亡,占全球死亡人数的74%。全球肥胖、糖尿病和心血管疾病等疾病的盛行率不断上升,以及药品和营养补充剂使用的增加,促使对空心硬胶囊的需求增加。
胶囊易于吞嚥,可以掩盖药物的味道,这也有利于患者的依从性,特别是在长期治疗计划中。这与以患者为中心的药物开发方法的更大行业趋势非常吻合。
区域视角
北美地区在 2022 年占据最大占有率,为 36.60%,预计在预测期内将以 5.70% 的复合年增长率增长,并在 2032 年达到超过 7.1 亿美元的规模。同时,亚太地区预计同期复合年增长率最高,达 8.89%。
北美两片空心硬胶囊市场预计将呈现稳定成长,前景看好。由于对医疗保健基础设施的投资和公众对现代医学意识的提高,预计市场将进一步扩大。
本报告调查了全球两片空心硬胶囊市场,提供了市场定义和概述,影响市场成长和市场机会的因素分析,市场规模的趋势和预测,并按各个细分市场、地区和主要国家进行了细分。
Global Two-Piece Empty Hard Capsule Market Research Report Information by Raw Material (Gelatin Hydroxypropyl Methylcellulose (HPMC), Starch and Pullulan), By size (Size "00" capsules, Size "0" capsules, Size "1" capsules, Size "2" capsules, others), By End Users (Pharmaceutical Companies, Health & Nutrition, Others) And by Region (North America, Europe, Asia-Pacific, And Rest of The World) - Forecast Till 2032
The size of the two-piece empty hard capsule market was estimated at USD 1.13 billion in 2023 and is expected to increase at a compound yearly growth rate (CAGR) of 7.08% from USD 1.20 billion in 2024 to USD 2.23 billion by 2032.
The market for two-piece empty hard capsules is expanding rapidly, driven mostly by the rising incidence of non-communicable diseases (NCDs). The World Health Organization (WHO) estimates that noncommunicable diseases (NCDs) would kill 41 million people year in 2023, making up 74% of all deaths globally. The demand for empty hard capsules has increased as a result of the increased use of pharmaceutical and nutraceutical therapies due to the rising prevalence of disorders including obesity, diabetes, and cardiovascular diseases around the world. These capsules are effective drug delivery systems that make it easier to provide different formulations to treat the complicated issues related to non-communicable diseases. Pharmaceutical companies are using two-piece empty hard capsules to encapsulate a wide range of medicinal substances, taking advantage of their adaptability as healthcare systems worldwide attempt to control and cure these common chronic illnesses.
Because the capsules are easy to swallow and hide the taste of pharmaceuticals, they also have a benefit in terms of patient compliance, particularly in long-term treatment regimes. This fits well with the larger industry trend of drug development methodologies that are patient centric.
Insights on Market Segments
Based on raw material, the global Two-Piece Empty Hard capsule segmentation comprises pullulan, gelatin, hydroxypropyl methylcellulose (HPMC), and starch.
Size-based market segmentation for two-piece empty hard capsules comprises of capsules with a "00" size, "0" size, "1" size, "2" size, and other sizes.
The end-user segmentation of the two-piece empty hard capsule market includes pharmaceutical businesses, health and nutrition, and other categories.
RegionalPerspectives
With the biggest market share of 36.60% in 2022, the North American two-piece empty hard capsule market is expected to grow at a 5.70% CAGR to reach over USD 0.71 billion by 2032. Nonetheless, throughout the course of the projection period, Asia-Pacific is expected to develop at the highest CAGR of 8.89%.
The two-piece empty hard capsule market in North America has a good future ahead of it, with steady growth predicted. Further market expansion is anticipated because of investments in healthcare infrastructure and rising public awareness of modern medical treatments.
Due to rising healthcare costs, the prevalence of chronic diseases, and technological improvements, the Europe Two-Piece Empty Hard Capsule Market had the second-largest market share.
The market for two-piece empty hard capsules in the Asia-Pacific region is anticipated to develop at the quickest rate between 2024 and 2032 due to the region's high patient population, rise in chronic illnesses, and advantageous regulatory framework. The expansion of major companies in the Two-Piece Empty Hard Capsule Market into this area is also propelling the growth of the regional market.
Principal Players
Important Businesses CapsCanada (Canada), Roxlor (US), Goerlich Pharma GmbH (Europe), Lonza (Switzerland), Qualicaps (US), Suheung (South Korea), ACG (India), Hunan Er-Kang Pharmaceutical Co. Ltd (China), Shanxi Guangsheng Medicinal Capsule Co., Ltd (China), and Bright Pharma Caps (US) are some of the companies that sell two-piece empty hard capsules on the market.